<DOC>
	<DOCNO>NCT00021125</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . It yet know regimen radiation therapy effective head neck cancer . PURPOSE : Randomized phase III trial compare effectiveness different regimen radiation therapy treat patient head neck cancer .</brief_summary>
	<brief_title>Radiation Therapy Treating Patients With Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare adjuvant continuous hyperfractionated accelerated radiotherapy vs conventional radiotherapy , term prevent disease recurrence , patient head neck cancer . - Compare early late toxic effect treatment patient population . - Compare disease-free overall survival patient receive treatment . - Assess quality life patient receive treatment . OUTLINE : This randomize , multicenter study . Patients randomize one two treatment arm . - Arm I : Patients undergo radiotherapy 3 time daily , interval least 6 hour 2 treatment , 5 day week , 2 week , total 13-14 treatment day . - Arm II : Patients undergo radiotherapy daily , 5 day week , 6-6.5 week . Quality life assess baseline annually 5 year . Patients follow every 3 month 3 year , every 6 month 2 year , annually thereafter . PROJECTED ACCRUAL : A total 460 patient ( 230 per arm ) accrue study within 2-3 year .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Skin Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm squamous cell carcinoma head neck include , limited , follow : Oral cavity Oropharynx Hypopharynx Larynx Nasal sinuses Skin Undergone curative surgery within past 70 day All macroscopic disease remove At high intermediate risk recurrence No low risk recurrence No evidence distant metastasis Considered treatable radiotherapy PATIENT CHARACTERISTICS : Age : Not specify Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No prior concurrent malignancy would preclude study participation No uncontrolled medical illness would preclude study participation PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy See Disease Characteristics Surgery See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2002</verification_date>
	<keyword>squamous cell carcinoma skin</keyword>
	<keyword>stage I squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage II squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage I squamous cell carcinoma oropharynx</keyword>
	<keyword>stage II squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>stage I squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage II squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage I squamous cell carcinoma larynx</keyword>
	<keyword>stage II squamous cell carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>stage I squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage II squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage III squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>salivary gland squamous cell carcinoma</keyword>
	<keyword>stage I salivary gland cancer</keyword>
	<keyword>stage II salivary gland cancer</keyword>
	<keyword>stage III salivary gland cancer</keyword>
	<keyword>stage IV salivary gland cancer</keyword>
</DOC>